Outcomes of Combination Therapy for Chronic Antibody-Mediated Rejection in Renal Transplantation

被引：0
|
作者：
Kim, M. -G. [1 ]
Kwon, H. Y. [1 ]
Koo, T. Y. [1 ]
Kim, Y. J. [1 ]
Park, J. H. [2 ]
Yun, I. J. [3 ]
Park, Y. H. [4 ]
Chung, W. -K. [5 ]
Ahn, C. [1 ]
Yang, J. [1 ]
Ham, B. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul, South Korea
[2] KonKuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea
[3] KonKuk Univ, Dept Surg, Sch Med, Seoul, South Korea
[4] Gachon Univ Med & Sci, Dept Surg, Seoul, South Korea
[5] Gachon Univ Med & Sci, Dept Internal Med, Seoul, South Korea
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-02079
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1079
引用
收藏
页码：1049 / 1049
页数：1
相关论文
共 50 条
  • [1] Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation
    Kim, Myung-Gyu
    Kim, Yoon Jung
    Kwon, Hyuk Yong
    Park, Hayne Cho
    Koo, Tai Yeon
    Jeong, Jong Cheol
    Jeon, Hee Jung
    Han, Miyeun
    Ahn, Curie
    Yang, Jaeseok
    NEPHROLOGY, 2013, 18 (12) : 820 - 826
  • [2] Outcomes of Combination Therapy of Rituximab and High-Dose Intravenous Immunoglobulin for Chronic Antibody-Mediated Rejection in Renal Transplantation
    Kim, Y. J.
    Kim, M. -G.
    Ro, H.
    Yun, I. J.
    Ahn, C.
    Yang, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 290 - 290
  • [3] Outcomes of combination therapy including rituximab for antibody-mediated rejection after lung transplantation
    Keiji Yamanashi
    Toyofumi Fengshi Chen-Yoshikawa
    Masatsugu Hamaji
    Kimiko Yurugi
    Satona Tanaka
    Yojiro Yutaka
    Yoshito Yamada
    Daisuke Nakajima
    Akihiro Ohsumi
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 142 - 149
  • [4] Outcomes of combination therapy including rituximab for antibody-mediated rejection after lung transplantation
    Yamanashi, Keiji
    Chen-Yoshikawa, Toyofumi Fengshi
    Hamaji, Masatsugu
    Yurugi, Kimiko
    Tanaka, Satona
    Yutaka, Yojiro
    Yamada, Yoshito
    Nakajima, Daisuke
    Ohsumi, Akihiro
    Date, Hiroshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (02) : 142 - 149
  • [5] Antibody-mediated rejection following renal transplantation
    Sureshkumar, Kalathil K.
    Hussain, Sabiha M.
    Carpenter, Barbara J.
    Sandroni, Stephen E.
    Marcus, Richard J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 913 - 921
  • [6] ECULIZUMAB IN ANTIBODY-MEDIATED REJECTION OF PAEDIATRIC RENAL TRANSPLANTATION
    Roman-Ortiz, Elena
    Mendizabal, Santiago
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [7] Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
    Li, Jun
    Basler, Michael
    Alvarez, Gerardo
    Brunner, Thomas
    Kirk, Christopher J.
    Groettrup, Marcus
    KIDNEY INTERNATIONAL, 2018, 93 (03) : 670 - 680
  • [8] Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation
    Ishida, Hideki
    Omoto, Kazuya
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Nishida, Hayato
    Xiaobei, Li
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2008, 21 (06) : 602 - 604
  • [9] Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation
    Kumar, D.
    Gupta, G.
    Reeve, J.
    Sanghi, P.
    Bobba, S.
    Levy, M.
    Bhati, C.
    Kimball, P.
    Fattah, H.
    King, A.
    Massey, H.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 310 - 310
  • [10] Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation
    Ejaz, Nicole S.
    Alloway, Rita R.
    Halleck, Fabian
    Duerr, Michael
    Budde, Klemens
    Woodle, E. Steve
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 21 (17) : 2401 - 2418
12345